The Food and Drug Administration (FDA) is warning patients to be cautious when seeking prescriptions for weight loss drugs like Ozempic and Wegovy, due to a rise in counterfeit products on the market. These GLP-1 drugs help regulate blood sugar, slow digestion, and reduce appetite. Counterfeit versions of these medications can pose serious health risks, including incorrect dosing and adverse events.
In 2023, many patients turned to weight loss drugs as part of their New Year’s resolutions. However, due to high demand, legitimate prescriptions have become difficult to obtain. Some online companies claim to offer “quick fixes” with fake prescriptions, often through unverified websites and social media ads. This can lead to hazardous counterfeits that lack proper quality control.
To spot counterfeit Ozempic needles, look for a blue area on the side containing a lot number. Patients should only purchase medications from reputable pharmacies or licensed compounding pharmacies. The FDA recommends consulting with healthcare providers and educating patients about dosing and injection processes.
Weight loss experts emphasize the importance of tracking muscle mass and overall health while taking these medications. This can help prevent adverse events, such as weight gain due to decreased physical activity. Some gyms and fitness centers offer specialized programs for patients on GLP-1 drugs, providing personalized guidance and support.
As one patient reported, using a legitimate weight loss program with the guidance of healthcare professionals made all the difference in achieving her goals without relying solely on medication. The FDA cautions against stigmatizing weight loss medications, emphasizing their potential to help individuals manage obesity and improve overall health.
Source: https://www.cbsnews.com/newyork/news/counterfeit-weight-loss-drugs-fda-warning